新生儿多病共存对极低出生体重儿远期结局预测能力有限
该研究基于Vermont Oxford Network 2010-2020年8332例存活极低出生体重儿(<1000 g)的24月龄随访数据,比较三种多病共存模型对发育迟缓、再住院和治疗服务使用的预测能力。
要点
- 三种多病共存模型对24月龄不良结局的预测能力均有限(AUC=0.66)。
- 需更全面刻画多病严重度、生理影响和环境因素以提升预测效用。
核心结论
- 新生儿多病共存与极低出生体重儿远期健康和发育结局相关,但基于诊断的多病共存风险模型预测能力较差。
研究设计与样本
- 研究纳入2010-2020年北美Vermont Oxford Network中8332例存活极低出生体重儿(<1000 g),随访至24月龄纠正年龄。
- 比较三种经胎龄调整的风险模型:疾病计数、三种特定疾病计数(支气管肺发育不良、脑室内出血、早产儿视网膜病变)和多病共存潜在类别。
主要发现
- 疾病计数和多病共存潜在类别与无疾病相比与24月龄不良结局风险增加相关。
- 所有三种模型的预测能力均一般,受试者工作特征曲线下面积(AUC)=0.66。
临床怎么用
- 临床不应仅依赖基于诊断的多病共存模型预测极低出生体重儿的远期结局。
- 需结合多病严重度、生理影响和环境因素等更全面信息进行风险评估。
局限性
- 研究未报告模型校准度、外部验证等细节,可能影响结论的普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test and compare the capability of 3 multimorbidity-based models to predict outcomes in early childhood among infants born with extremely low birth weight (<1000 g, ELBW). STUDY DESIGN: Participants included 8332 surviving ELBW infants born 2010-2020 in North America who contributed follow-up data at 24-months corrected age to the Vermont Oxford Network. Neonatal morbidities included bronchopulmonary dysplasia, grade 3-4 intraventricular hemorrhage, periventricular leukomalacia, stage 3-4 retinopathy of prematurity, late infection, necrotizing enterocolitis, and spontaneous intestinal perforation. Outcomes included: 1) developmental delay (Bayley score <70 in ≥1 domain), 2) rehospitalization, and 3) therapeutic service use. We compared 3 gestational age-adjusted risk models with the following predictors: 1) morbidity count, 2) count of 3 morbidities (bronchopulmonary dysplasia, intraventricular hemorrhage, and retinopathy of prematurity), and 3) multimorbidity-based latent classes. RESULTS: Thirty five percent of the study sample had ≥2 neonatal morbidities. Most (64%) received ≥2 therapeutic services, 36% were re-hospitalized, and 19% had developmental delay at 24-months. Morbidity counts and multimorbidity-based latent classes were associated with increased risk for poor 24-month outcomes compared with no morbidity. However, the predictive ability of all 3 models was modest (area under the receiver operating curve = 0.66). CONCLUSIONS: Neonatal multimorbidity is common among ELBW infants and associated with later health and developmental outcomes. However, diagnosis-based multimorbidity risk models have poor prognostic ability. More robust characterization of multimorbidity symptom severity, physiologic impact, and environmental correlates may improve the clinical utility of future risk models.
引用
- Litt JS, Belfort MB, Edwards EM, et al. Neonatal Multimorbidity is a Poor Predictor of Health and Developmental Outcomes after Preterm Birth. J Pediatr. 2025. PMID: 41391543. doi:10.1016/j.jpeds.2025.114948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。